Glucose uptake and consumption were improved in the rapamycin plus TNF-α or IL-6 groups compared with cells treated with TNF-α or IL-6 alone in the absence and presence of insulin (Fig. 1a–f), suggesting that rapamycin ameliorates inflammatory stress-induced insulin resistance in vitro. The gene discussed is IL6; the disease is Insulin resistance.